what are glp-1 receptor agonists GLP-1 Receptor Agonists Explained for

FDA is acknowledging that the drugs dont have the same risk seen with older weight-loss medicines

Discover the research, how they work, who should try these, and more.

At 12 months, weight loss persisted at around 4%, with variability between agents, most notably liraglutide

CU Anschutz Cancer Center researchers are looking to see if GLP-1 drugs like Ozempic and Wegovy improve the immune system.

The Weight Hacker: Women who want to lose weight in a healthier way, without going on dangerous medications

The Risks: Unknown ingredients and contamination Incorrect dosages and life-threatening side effects No regulatory oversight or safety data Why This Is Critical: Patients are bypassing pharmacies and getting injections from sketchy online vendors This undermines real GLP1 therapies and can lead to serious harm As healthcare professionals, we must: Ask patients about the source of their medications Report adverse reactions to MedWatch Educate our patients about safe access and real prescriptions Lets advocate for ethical prescribing and responsible patient care in the GLP1 era